Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$9.02 - $13.5 $609,192 - $911,763
-67,538 Closed
0 $0
Q3 2021

Nov 18, 2021

SELL
$13.71 - $17.18 $105,114 - $131,719
-7,667 Reduced 10.19%
67,538 $962,000
Q2 2021

Aug 16, 2021

BUY
$14.92 - $23.23 $1.12 Million - $1.75 Million
75,205 New
75,205 $1.25 Million
Q1 2021

May 17, 2021

SELL
$7.33 - $21.06 $259,870 - $746,640
-35,453 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$3.63 - $7.53 $128,694 - $266,961
35,453 New
35,453 $267,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $406M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.